Intel Corporation is extending his European presence on the eHealth market

intelIntel Corporation, in conjunction with the IDA Ireland (Industrial Development Agency) have started a research initiative based in Ireland to address the growing wave of ageing citizens in Europe and around the world, according to the recent news article from the Technology Research for Independent Living (TRIL) Centre.

Eric Dishman, General Manager and Global Director of Intel's Health Research & Innovation Group explained the significance of the TRIL Centre, "The Technology Research for Independent Living Centre... or TRIL Centre for short... was borne out of that excitement, expertise, and collaborative commitment. Our goal is to accelerate research, development, and commercialisation of independent living technologies that help older people to live in their homes of choice, even in the midst of age-related illnesses and injuries that are becoming so commonplace. Bringing together Intel researchers with interdisciplinary researchers from University College Dublin, Trinity College Dublin and National University of Ireland, Galway, the TRIL Centre is one of the world's largest R&D collaborations on this important topic, and we hope to make Ireland an international centre of excellence for this work."

Intel as the world leader in silicon innovation has reorginised itself and now is focusing his attention on five key market segment opportunities: mobility, digital home, enterprize, health and channel. In this context is very important to mention Intel's very promising and powerfull US based division (named Digital Health) which now is starting to establish a strong presence on the European eHealth / Healthcare IT market.

Close to the European presence, Intel has created the Behavioral Assessment and Intervention Commons (BAIC), a unique US based academic-industrial collaboration that constructs a research commons - a shared pool of tools, technology and thinking - around behavioral markers and health outcomes. This collaboration, strengthened recently by $1 million grant involved the Oregon Health & Science University (OHSU) on assessment and intervention for age-related conditions such as Alzheimer's disease and injuries from falls.

Related news articles:

Intel, the Intel logo, "Intel. Leap ahead." and "Intel. Leap ahead." logo are trademarks or registered trademarks of Intel Corporation or its subsidiaries in the United States and other countries.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...